Anne‐Lise Børresen

3.4k total citations · 1 hit paper
56 papers, 2.4k citations indexed

About

Anne‐Lise Børresen is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Anne‐Lise Børresen has authored 56 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 19 papers in Oncology and 11 papers in Surgery. Recurrent topics in Anne‐Lise Børresen's work include Cancer-related Molecular Pathways (14 papers), Cancer Genomics and Diagnostics (6 papers) and Testicular diseases and treatments (5 papers). Anne‐Lise Børresen is often cited by papers focused on Cancer-related Molecular Pathways (14 papers), Cancer Genomics and Diagnostics (6 papers) and Testicular diseases and treatments (5 papers). Anne‐Lise Børresen collaborates with scholars based in Norway, United States and Sweden. Anne‐Lise Børresen's co-authors include Birgitte Smith‐Sørensen, Kåre Berg, Gösta Dahlén, Stephanie Geisler, Hilde Johnsen, Turid Aas, Jan Erik Varhaug, Lars A. Akslen, Per Eystein Lønning and Anton Brögger and has published in prestigious journals such as The Lancet, Nature Medicine and Environmental Health Perspectives.

In The Last Decade

Anne‐Lise Børresen

56 papers receiving 2.3k citations

Hit Papers

Specific P53 mutations are associated with de novo resist... 1996 2026 2006 2016 1996 200 400 600

Peers

Anne‐Lise Børresen
R J Coffey United States
H. Rabes Germany
E Tahara Japan
Ja June Jang South Korea
Andrea Gsur Austria
Waun Ki Hong United States
R J Coffey United States
Anne‐Lise Børresen
Citations per year, relative to Anne‐Lise Børresen Anne‐Lise Børresen (= 1×) peers R J Coffey

Countries citing papers authored by Anne‐Lise Børresen

Since Specialization
Citations

This map shows the geographic impact of Anne‐Lise Børresen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Lise Børresen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Lise Børresen more than expected).

Fields of papers citing papers by Anne‐Lise Børresen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne‐Lise Børresen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Lise Børresen. The network helps show where Anne‐Lise Børresen may publish in the future.

Co-authorship network of co-authors of Anne‐Lise Børresen

This figure shows the co-authorship network connecting the top 25 collaborators of Anne‐Lise Børresen. A scholar is included among the top collaborators of Anne‐Lise Børresen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne‐Lise Børresen. Anne‐Lise Børresen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aas, Turid, Anne‐Lise Børresen, Stephanie Geisler, et al.. (1996). Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nature Medicine. 2(7). 811–814. 608 indexed citations breakdown →
2.
Berner, Aasmund, Gry Aarum Geitvik, Frank Karlsen, et al.. (1995). TP53 mutations in prostatic cancer. Analysis of pre‐ and post‐treatment archival formalin‐fixed tumour tissue. The Journal of Pathology. 176(3). 299–308. 16 indexed citations
3.
Lothe, Ragnhild A., et al.. (1995). Alterations at Chromosome 17 Loci in Peripheral Nerve Sheath Tumors. Journal of Neuropathology & Experimental Neurology. 54(1). 65–73. 56 indexed citations
4.
Heimdal, Ketil, Ragnhild A. Lothe, Sophie D. Fosså, & Anne‐Lise Børresen. (1994). Association studies of a polymorphism in the Wilms' tumor 1 locus in norwegian patients with testicular cancer. International Journal of Cancer. 58(4). 523–526. 6 indexed citations
5.
Seruca, Raquel, Leonor David, Sérgio Castedo, et al.. (1994). p53 alterations in gastric carcinoma:. Cancer Genetics and Cytogenetics. 75(1). 45–50. 8 indexed citations
6.
Lothe, Ragnhild A., Nick Hastie, Ketil Heimdal, et al.. (1993). Frequent loss of 11p13 and 11p15 loci in male germ cell tumours. Genes Chromosomes and Cancer. 7(2). 96–101. 35 indexed citations
7.
Condie, Alison, Rosalind A. Eeles, Anne‐Lise Børresen, et al.. (1993). Detection of point mutations in the p53 gene: Comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques. Human Mutation. 2(1). 58–66. 88 indexed citations
8.
Heimdal, Ketil, et al.. (1993). No germline TP53 mutations detected in familial and bilateral testicular cancer. Genes Chromosomes and Cancer. 6(2). 92–97. 58 indexed citations
9.
Hovig, Eivind, Erik Mullaart, Anne‐Lise Børresen, André G. Uitterlinden, & Jan Vijg. (1993). Genome Scanning of Human Breast Carcinomas Using Micro- and Minisatellite Core Probes. Genomics. 17(1). 66–75. 13 indexed citations
10.
Smith‐Sørensen, Birgitte, Mark C. Gebhardt, Peter Kloen, et al.. (1993). Screening for TP53 mutations in osteosarcomas using constant denaturant gel electrophoresis (CDGE). Human Mutation. 2(4). 274–285. 33 indexed citations
11.
Ottestad, Lars, Tone Ikdahl Andersen, Jahn M. Nesland, et al.. (1993). Amplification of c-erbB-2, int-2 and c-myc Genes in Node-Negative Breast Carcinomas: Relationship to Prognosis. Acta Oncologica. 32(3). 289–294. 11 indexed citations
12.
Hovig, Eivind, Birgitte Smith‐Sørensen, Mark C. Gebhardt, et al.. (1992). No alterations in exon 21 of the RBI gene in sarcomas and carcinomas of the breast, colon, and lung. Genes Chromosomes and Cancer. 5(2). 97–103. 8 indexed citations
13.
Børresen, Anne‐Lise. (1992). Role of Genetic Factors in Breast Cancer Susceptibility. Acta Oncologica. 31(2). 151–155. 12 indexed citations
14.
Peltomäki, Païvi, Ragnhild A. Lothe, Anne‐Lise Børresen, et al.. (1992). Chromosome 12 in human testicular cancer: Dosage changes and their parental origin. Cancer Genetics and Cytogenetics. 64(1). 21–26. 9 indexed citations
15.
Andersen, Tone Ikdahl, Anne‐Lise Børresen, George Farrants, et al.. (1992). Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Genes Chromosomes and Cancer. 4(2). 113–121. 93 indexed citations
17.
Peltomäki, Païvi, Ragnhild A. Lothe, Anne‐Lise Børresen, et al.. (1991). Altered dosage of the sex chromosomes in human testicular cancer: A molecular genetic study. International Journal of Cancer. 47(4). 518–522. 16 indexed citations
18.
Hovig, Eivind, Birgitte Smith‐Sørensen, Anton Brögger, & Anne‐Lise Børresen. (1991). Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detection. Mutation Research Letters. 262(1). 63–71. 107 indexed citations
19.
Børresen, Anne‐Lise, Tone Ikdahl Andersen, Steinar Tretli, Arvid Heiberg, & Pål Møller. (1990). Breast cancer and other cancers in Norwegian families with ataxia‐telangiectasia. Genes Chromosomes and Cancer. 2(4). 339–340. 95 indexed citations
20.
Børresen, Anne‐Lise, Eivind Hovig, & Anton Brögger. (1988). Detection of base mutations in genomic DNA using denaturing gradient gel electrophoresis (DGGE) followed by transfer and hybridization with gene-specific probes. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 202(1). 77–83. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026